Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.

ABSTRACT:

Importance

Several studies reported sharp decreases in screening mammography for breast cancer and low-dose computed tomographic screening for lung cancer in the early months of the COVID-19 pandemic, followed by a return to normal or near-normal levels in the summer of 2020.

Objective

To determine the observed vs expected mammography and low-dose computed tomographic scan rates from the beginning of the pandemic through April 2022.

Design, setting, and participants

In this retrospective cohort study assessing mammography and low-dose computed tomography rates from January 2017 through April 2022, data for January 2016 to February 2020 were used to generate expected rates for the period March 2020 to April 2022. The study included a 20% national sample of Medicare fee

SUBMITTER: Doan C 

PROVIDER: S-EPMC9898823 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature